Drug Labeling

BIG News from the FDA Today!

By NWHN Staff | Mar 30, 2016 | Comments Off on BIG News from the FDA Today!

Today, the FDA announced major (and long overdue!) changes to the Mifeprex® (medication abortion pill) label.

FDA Scientific Workshop – Labeling of Low-Dose Vaginal Estrogen Products

By Cindy Pearson | Nov 13, 2015 | Comments Off on FDA Scientific Workshop – Labeling of Low-Dose Vaginal Estrogen Products

Food and Drug Administration Scientific Workshop on Labeling Lower-Dose Estrogen-Alone Products for Symptoms of Vulvar and Vaginal Atrophy

FDA Scientific Workshop – Drug Interactions With Hormonal Contraceptives

By Christina Cherel | Nov 9, 2015 | Comments Off on FDA Scientific Workshop – Drug Interactions With Hormonal Contraceptives

Food and Drug Administration Hormonal Contraception Public Workshop on Drug Interactions with Hormonal Contraceptives: Public Health and Drug Development Implications

Generic Drugs

By NWHN Staff | Aug 13, 2015 | Comments Off on Generic Drugs

More than 80 percent of prescriptions filled in the United States are for generic drugs. Women get these prescriptions with the assumption that the drugs they’ve been prescribed are safe and effective.

FDA Meeting – Generic Drug Labeling

By Coco Jervis | Mar 27, 2015 | Comments Off on FDA Meeting – Generic Drug Labeling

Statement of Coco Jervis, J.D., Program Director |
Food and Drug Administration Public Meeting on Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products